Literature DB >> 17429599

Natriuretic peptide receptor B signaling in the cardiovascular system: protection from cardiac hypertrophy.

Ines Pagel-Langenickel1, Jens Buttgereit, Michael Bader, Thomas H Langenickel.   

Abstract

Natriuretic peptides (NP) represent a family of structurally homologous but genetically distinct peptide hormones involved in regulation of fluid and electrolyte balance, blood pressure, fat metabolism, cell proliferation, and long bone growth. Recent work suggests a role for natriuretic peptide receptor B (NPR-B) signaling in regulation of cardiac growth by either a direct effect on cardiomyocytes or by modulation of other signaling pathways including the autonomic nervous system. The research links NPR-B for the first time to a cardiac phenotype in vivo and underlines the importance of the NP in the cardiovascular system. This manuscript will focus on the role of NPR-B and its ligand C-type natriuretic peptide in cardiovascular physiology and disease and will evaluate these new findings in the context of the known function of this receptor, with a perspective on how future research might further elucidate NPR-B function.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17429599     DOI: 10.1007/s00109-007-0183-4

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  125 in total

1.  An insertion/deletion polymorphism in intron 18 of the type B human natriuretic peptide receptor gene is not associated with cerebral infarction.

Authors:  D Rahmutula; T Nakayama; M Soma; Y Takahashi; J Uwabo; M Sato; Y Izumi; K Kanmatsuse; Y Ozawa
Journal:  Hypertens Res       Date:  2000-03       Impact factor: 3.872

2.  C-type natriuretic peptide has a negative inotropic effect on cardiac myocytes.

Authors:  A Nir; D F Zhang; R Fixler; J C Burnett; Y Eilam; Y Hasin
Journal:  Eur J Pharmacol       Date:  2001-02-02       Impact factor: 4.432

3.  Structure of the type B human natriuretic peptide receptor gene and association of a novel microsatellite polymorphism with essential hypertension.

Authors:  D Rehemudula; T Nakayama; M Soma; Y Takahashi; J Uwabo; M Sato; Y Izumi; K Kanmatsuse; Y Ozawa
Journal:  Circ Res       Date:  1999-03-19       Impact factor: 17.367

4.  Natriuretic peptide system gene expression in human coronary arteries.

Authors:  Victor H Casco; John P Veinot; Mercedes L Kuroski de Bold; Roy G Masters; Michelle M Stevenson; Adolfo J de Bold
Journal:  J Histochem Cytochem       Date:  2002-06       Impact factor: 2.479

5.  Furin-mediated processing of Pro-C-type natriuretic peptide.

Authors:  Chengliang Wu; Faye Wu; Junliang Pan; John Morser; Qingyu Wu
Journal:  J Biol Chem       Date:  2003-05-07       Impact factor: 5.157

6.  Cardiac hypertrophy in transgenic rats expressing a dominant-negative mutant of the natriuretic peptide receptor B.

Authors:  Thomas H Langenickel; Jens Buttgereit; Ines Pagel-Langenickel; Maren Lindner; Jan Monti; Knut Beuerlein; Nidal Al-Saadi; Ralph Plehm; Elena Popova; Jens Tank; Rainer Dietz; Roland Willenbrock; Michael Bader
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-14       Impact factor: 11.205

7.  Rat atrial natriuretic factor: complete amino acid sequence and disulfide linkage essential for biological activity.

Authors:  K S Misono; H Fukumi; R T Grammer; T Inagami
Journal:  Biochem Biophys Res Commun       Date:  1984-03-15       Impact factor: 3.575

8.  Presence of C-type natriuretic peptide in cultured human endothelial cells and plasma.

Authors:  A J Stingo; A L Clavell; D M Heublein; C M Wei; M R Pittelkow; J C Burnett
Journal:  Am J Physiol       Date:  1992-10

9.  Effect of native and synthetic atrial natriuretic factor on cyclic GMP.

Authors:  P Hamet; J Tremblay; S C Pang; R Garcia; G Thibault; J Gutkowska; M Cantin; J Genest
Journal:  Biochem Biophys Res Commun       Date:  1984-09-17       Impact factor: 3.575

10.  Vascular endothelial growth factor suppresses C-type natriuretic peptide secretion.

Authors:  K Doi; H Itoh; Y Komatsu; T Igaki; T H Chun; K Takaya; J Yamashita; M Inoue; T Yoshimasa; K Nakao
Journal:  Hypertension       Date:  1996-03       Impact factor: 10.190

View more
  11 in total

Review 1.  Molecular mechanisms underlying cardiac antihypertrophic and antifibrotic effects of natriuretic peptides.

Authors:  Camilla Calvieri; Speranza Rubattu; Massimo Volpe
Journal:  J Mol Med (Berl)       Date:  2011-08-09       Impact factor: 4.599

Review 2.  BNP molecular forms and processing by the cardiac serine protease corin.

Authors:  Tomoko Ichiki; Brenda K Huntley; John C Burnett
Journal:  Adv Clin Chem       Date:  2013       Impact factor: 5.394

3.  Elevated C-type natriuretic peptide elicits exercise preconditioning-induced cardioprotection against myocardial injury probably via the up-regulation of NPR-B.

Authors:  Jiao Lu; Shan-Shan Pan
Journal:  J Physiol Sci       Date:  2016-08-24       Impact factor: 2.781

4.  C-type natriuretic peptide slows down wound healing but promotes angiogenesis in SKH1-hr hairless mice.

Authors:  Andreas Kuehnl; Jaroslav Pelisek; André Ring; Nick Spindler; Rudolf Hatz; Karl-Walter Jauch; Hans-Henning Eckstein; Stefan Langer
Journal:  Int Wound J       Date:  2012-06-14       Impact factor: 3.315

5.  Discovery of novel small molecule inhibitors of cardiac hypertrophy using high throughput, high content imaging.

Authors:  Brian G Reid; Matthew S Stratton; Samantha Bowers; Maria A Cavasin; Kimberley M Demos-Davies; Isidro Susano; Timothy A McKinsey
Journal:  J Mol Cell Cardiol       Date:  2016-04-27       Impact factor: 5.000

6.  C-Type Natriuretic Peptide Improves Left Ventricular Functional Performance at Rest and Restores Normal Exercise Responses after Heart Failure.

Authors:  Tiankai Li; Heng-Jie Cheng; Nobuyuki Ohte; Hiroshi Hasegawa; Atsushi Morimoto; David M Herrington; William C Little; Weimin Li; Che Ping Cheng
Journal:  J Pharmacol Exp Ther       Date:  2016-03-29       Impact factor: 4.030

7.  Defective cellular trafficking of missense NPR-B mutants is the major mechanism underlying acromesomelic dysplasia-type Maroteaux.

Authors:  Alistair N Hume; Jens Buttgereit; Aydah M Al-Awadhi; Sarah S Al-Suwaidi; Anne John; Michael Bader; Miguel C Seabra; Lihadh Al-Gazali; Bassam R Ali
Journal:  Hum Mol Genet       Date:  2008-10-22       Impact factor: 6.150

8.  Novel mutations in natriuretic peptide receptor-2 gene underlie acromesomelic dysplasia, type maroteaux.

Authors:  Saadullah Khan; Raja Hussain Ali; Sanaullah Abbasi; Muhammad Nawaz; Noor Muhammad; Wasim Ahmad
Journal:  BMC Med Genet       Date:  2012-06-12       Impact factor: 2.103

9.  Comparative measurement of CNP and NT-proCNP in human blood samples: a methodological evaluation.

Authors:  Andreas Kuehnl; Jaroslav Pelisek; Martin Bruckmeier; Wajima Safi; Hans-Henning Eckstein
Journal:  J Negat Results Biomed       Date:  2013-04-01

10.  Chronic C-Type Natriuretic Peptide Infusion Attenuates Angiotensin II-Induced Myocardial Superoxide Production and Cardiac Remodeling.

Authors:  Yasuhiro Izumiya; Satoshi Araki; Hiroki Usuku; Taku Rokutanda; Shinsuke Hanatani; Hisao Ogawa
Journal:  Int J Vasc Med       Date:  2012-07-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.